We've translated early information from genetic research...

We've translated early information from genetic research into valuable medicines for HIV/AIDS, heart disease and the prevention of organ rejection. But these advances have only scratched the surface of possible revolutionary approaches to treat and cure diseases. Pfizer, the NIH and other public/private biomedical research interests have complementary missions greater than the sum of their parts. Our hope is that this public/private initiative will encourage a deeper collective understanding of the genetic factors of disease for major new therapeutic advances.